2nd Quarter - Termination

PATIENTSACT for PATIENTSACT

Firm
Client
Income
—
Expenses
$120,000
Expense method
A: Lobbying Disclosure Act definitions
Terminated
May 28, 2026

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Attention to reimbursement and regulatory issues impacting access to treatment of skin conditions. Skin cancer issues as they relate to the Physician Fee Schedule.

LobbyistCovered position, as disclosed
MATTHEW BASSETT —

Medical/Disease Research/Clinical Labs MED

Attention to reimbursement and regulatory issues impacting access to treatment of skin conditions. Skin cancer issues as they relate to the Physician Fee Schedule.

LobbyistCovered position, as disclosed
MATTHEW BASSETT —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.